Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. - Wikidata - wikimedia - TriplyDB

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.

http://www.wikidata.org/entity/Q37420782

about

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer.Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer Vitamin d: are we ready to supplement for breast cancer prevention and treatment?Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.

P2860

Q22305894-64C33776-3E21-46FD-8299-2A2AD7C4799C Q33577607-CC72D21B-2F6C-43B8-B890-31A597456AC6 Q34021008-8B64B49F-B371-4E75-AFE4-FF2E89FC2C72 Q34795858-C311E462-32B6-4F42-852A-F0110D6000B6 Q35429388-2FB08419-F0F0-4AB6-9FBF-DA1AE5EE7E36 Q36043460-B125F2C9-A9F9-43DC-9FE2-6B78C9E26AE2 Q36468811-B3E9026E-1300-40F8-94BE-A7461CD6C9CD Q36638586-F885549E-84AA-4E96-88FC-43D7282BD199 Q36654640-734FDC42-5D7A-4F9E-8BB4-73BAB184F1C7 Q36692336-AC810588-6FEF-4F85-9DF9-C9D3FB066DA4 Q40098705-4152F0E7-BF54-4576-A5C3-1858EA62369B Q43777076-CE1842FC-CDA0-456B-A1D9-4ADC3DD7BF33 Q45119447-C4AD67D1-C976-431B-99CA-50C673B172BA Q47120813-5B785359-FC4E-496B-8C02-D0FA7F66657F

P2860

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer.

http://www.wikidata.org/entity/Q37420782

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@en

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@nl

type

label

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@en

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@nl

prefLabel

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@en

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@nl

P1433

Q37420782-AAA2EED8-DFE1-4A7E-89FA-E3AD7FA5D222

P1476

Q37420782-628149B2-398E-49AF-9F0C-7BA9F2686ADC

P2093

Q37420782-2EE4D263-D984-4BCA-B8A5-7B85A5672FCA

Q37420782-59D4AA0A-086A-45F3-BC56-CF6FEB90F148

Q37420782-664B1483-641C-4EAA-833A-07FDC1022811

Q37420782-6ED2A0A3-5170-4A6F-AEED-97A4B4B7FF0F

Q37420782-7468BB4A-3124-4D39-B899-BA62B4989F08

Q37420782-8127FDB8-0257-4429-A0FB-1E79F5D32074

Q37420782-8C80E2CE-80D0-4A22-900A-7F45E3DEFCFA

Q37420782-95AA6FFC-FE06-4B3A-B0DE-D32724A73635

Q37420782-A34C879B-3050-4F71-BF21-1252DEC75F35

Q37420782-D09531F0-333B-4C3A-8D62-CC0D0C0A7242

P2860

Q37420782-09D4C33C-1436-4DC8-92A4-658F54248564

Q37420782-0EEF1BB4-3D48-48EA-9E6B-504F22B13F14

Q37420782-1435A79F-D086-470F-BF52-13D65028154D

Q37420782-16F31F89-C153-464B-8C79-605C40BF17C7

Q37420782-1C19AD8D-D976-4DFB-8FA4-A51245AC2192

Q37420782-2D245478-23B1-4157-A08E-CA0CE85449A8

Q37420782-36E997E3-616E-4535-99E5-4F7547281176

Q37420782-6F798FFC-149C-484B-B1A1-DB1281403C63

Q37420782-7E13E6A4-DFEE-4CFB-B078-E578D82CFE9D

Q37420782-8C0E381F-15E5-4BCC-A185-2872EAC2A8F0

P2888

Q37420782-1DC23DDB-46ED-441E-B1D6-1846C113453F

P304

Q37420782-3989B8F9-120C-414A-BFB6-9D0FED31BC93

P31

Q37420782-7CB34824-2BC7-4423-AA12-ED963A938926

P356

Q37420782-C0DE4786-83AE-443D-9C4C-EA795AE5AAB5

P407

Q37420782-96F365C3-BC01-4423-9A17-761D8EA7BCD3

P433

Q37420782-0C93EA08-1519-4456-BC0F-AF48B4F659D6

P478

Q37420782-55133F70-63C7-4DBB-B2A1-BFFA4B0CAB67

P577

Q37420782-9D5C7999-A11C-4C30-A0F0-4F0694697CDC

P5875

Q37420782-5B5CB39E-9168-4589-B6CE-797B2D7A3482

P6179

Q37420782-92B39023-7EB9-4CC9-B053-3823C33DDD93

P698

Q37420782-654E623E-5F2C-46B1-9E7D-A8EAA63A489D

P921

Q37420782-05EA4436-7238-4592-8BA1-B07B3E85F736

Q37420782-9488135F-6128-457A-8767-F2E1A61F75A8

P932

Q37420782-4785569D-FCFE-4655-8F0B-005B4DBA08C6

P356

P1433

British Journal of Cancer

P1476

Vitamin D receptor polymorphis ...... ith epithelial ovarian cancer.

@en

P2093

A Okamoto

http://www.w3.org/2001/XMLSchema#string

A Shimojima

http://www.w3.org/2001/XMLSchema#string

C Norizoe

http://www.w3.org/2001/XMLSchema#string

D Takahashi

http://www.w3.org/2001/XMLSchema#string

K Ochiai

http://www.w3.org/2001/XMLSchema#string

M Urashima

http://www.w3.org/2001/XMLSchema#string

N Yanaihara

http://www.w3.org/2001/XMLSchema#string

S Tamez

http://www.w3.org/2001/XMLSchema#string

T Tanaka

http://www.w3.org/2001/XMLSchema#string

Y Tsutsumi

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D deficiency

Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.

Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer.

Advances in treatment of epithelial ovarian cancer.

Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer.

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer

Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.

Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.

A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women.

P2888

P304

1957-1960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605414

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38080860

http://www.w3.org/2001/XMLSchema#string

P6179

1037660344

http://www.w3.org/2001/XMLSchema#string

P698

19904266

http://www.w3.org/2001/XMLSchema#string

P921

P932

2777264

http://www.w3.org/2001/XMLSchema#string